CT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Themes
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About Us
Advertise With Us
Contact Us
Our Marketing Solution
GlobalData Reports
Visit GlobalData
From Our Partners
Optimizing Cell & Gene Therapy Processes
Accelerating Clinical Trials
Advancing research with digital-first clinical trials
Improving decentralised trials with mobile research nursing
The new era of global patient recruitment
The next chapter of clinical trial services
Trusted clinical trial packaging services
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Tackling the unmet therapeutic needs in stimulant use disorder
Pipeline moves: Prospects drop after investigator-led trial of Roche’s Tecentriq terminated
Sustainability challenges in rare disease trials remain, but change is happening
Sectors
Sections
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Latest
Nuvation Bio begins subject dosing in Phase I/II solid tumour trial
Recce concludes cohort dosing in UTI/Urosepsis treatment trial
OcuTerra’s Phase II diabetic retinopathy trial misses endpoints
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Sativex (Nabiximols) for the Treatment of Multiple Sclerosis, Europe
Kiromic activates new clinical site for Phase I NSCLC treatment trial
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Q4 2023 update: M&A activity in pharmaceutical in the US
Q4 2023 update: M&A activity in pharmaceutical in Middle East and Africa
Q4 2023 update: M&A activity in pharmaceutical in Italy
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
PRPs: What is a Patient Recruitment Platform (and why do you need one)?
Quality versus quantity in T-cell production: Why it doesn’t have to be a trade-off
The key products you need to trust your host-cell protein analysis and other process related impurity results
Events
Reports
Premium Insights
Newsletters
CT
health apps
Virtual therapy: Health tech at-a-distance will outlast the Covid status quo
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
View more